Skip to content

API Data Insights

Numbers don’t lie, companies do

  • All News
  • Deep Dives
  • Signals
  • Case Files
  • Opinion
  • Exposés
  • Regulatory

Newswire

All of Us Program Leverages Patient Data-Sharing Networks to Enhance Real-World Data Collection
Newswire

All of Us Program Leverages Patient Data-Sharing Networks to Enhance Real-World Data Collection

July 20, 2026
A boundary-pushing federal health research program has secured thousands of electronic medical records as it…
Class 3 Medicines Recall: Flamingo Pharma UK Ltd, Flucloxacillin Capsules BP 500mg, EL(26)A/32
Newswire

Class 3 Medicines Recall: Flamingo Pharma UK Ltd, Flucloxacillin Capsules BP 500mg, EL(26)A/32

July 20, 2026
Flamingo Pharma UK Ltd has issued a Class 3 medicines recall for specific packs of…
Relonchem Limited Issues Class 4 Medicines Defect Notification for Gabapentin Oral Solution
Newswire

Relonchem Limited Issues Class 4 Medicines Defect Notification for Gabapentin Oral Solution

July 20, 2026
Relonchem Limited has notified the Medicines and Healthcare products Regulatory Agency (MHRA) of a Class…
After Monotherapy Failure, AbbVie and Genmab Tout Epkinly Combo Win in DLBCL
Newswire

After Monotherapy Failure, AbbVie and Genmab Tout Epkinly Combo Win in DLBCL

July 20, 2026
Despite a recent setback as a second-line monotherapy in diffuse large B-cell lymphoma (DLBCL), AbbVie…
FDA selects Lilly, Regeneron, Fujifilm, 4 others for PreCheck Pilot Program
Newswire

FDA selects Lilly, Regeneron, Fujifilm, 4 others for PreCheck Pilot Program

July 20, 2026
Eli Lilly, Regeneron, and Fujifilm are among the seven companies selected for the FDA’s PreCheck…
Talawar Therapeutics to debut on Nasdaq with $285m as Dupixent challenger
Newswire

Talawar Therapeutics to debut on Nasdaq with $285m as Dupixent challenger

July 19, 2026
Talawar Therapeutics is set to make its debut on Nasdaq, raising $285 million to advance…
Anixa Biosciences Secures Korean Patent for Breast Cancer Vaccine
Newswire

Anixa Biosciences Secures Korean Patent for Breast Cancer Vaccine

July 19, 2026
Anixa Biosciences has secured a patent from the Korean Ministry of Intellectual Property (MOIP) for…
Three years on: How is the industry coping with Annex 1?
Newswire

Three years on: How is the industry coping with Annex 1?

July 19, 2026
Three years after the implementation of the revised EU GMP Annex 1, the pharmaceutical industry…
Loophole in Trump’s Obesity Drug Deal Revealed by Eli Lilly and Novo Nordisk
Newswire

Loophole in Trump’s Obesity Drug Deal Revealed by Eli Lilly and Novo Nordisk

July 19, 2026
WASHINGTON — The Trump administration’s agreement with Eli Lilly and Novo Nordisk regarding GLP-1 obesity…
Trump Administration’s Actions Undermine Alcohol Addiction Research and Prevention Efforts
Newswire

Trump Administration’s Actions Undermine Alcohol Addiction Research and Prevention Efforts

July 19, 2026
The Trump administration’s approach to alcohol-related health issues has significantly hindered research and prevention efforts,…

About Us

For years we’ve built comprehensive pharmaceutical databases, collecting API, FDF, and excipient suppliers worldwide, with pricing and regulatory details.

Now we present this journal & store: coverage of pharma events, news, and market trends.

Read more →

Contact & Support

Company: API DATA

Location: Israel, Northern District — Gidona

Email: support@api-fdf.com

Connect

Explore our API & FDF Intelligence Database for structured insights on APIs, FDFs, excipients, and compliance worldwide.

Follow updates on LinkedIn.

  • Privacy Policy
  • About Us
  • Home
© API DATA, 2025. All rights reserved Theme: Eternal News By Artify Themes.